| Year |
Citation |
Score |
| 2022 |
Chai S, Smith CC, Kochar TK, Hunsucker SA, Beck W, Olsen KS, Vensko S, Glish GL, Armistead PM, Prins JF, Vincent BG. NeoSplice: a bioinformatics method for prediction of splice variant neoantigens. Bioinformatics Advances. 2: vbac032. PMID 35669345 DOI: 10.1093/bioadv/vbac032 |
0.324 |
|
| 2021 |
Truong AS, Zhou M, Krishnan B, Utsumi T, Manocha U, Stewart KG, Beck W, Rose TL, Milowsky MI, He X, Smith CC, Bixby LM, Perou CM, Wobker SE, Bailey ST, et al. Entinostat induces antitumor immune responses through immune editing of tumor neoantigens. The Journal of Clinical Investigation. 131. PMID 34396985 DOI: 10.1172/JCI138560 |
0.486 |
|
| 2021 |
Smith CC, Olsen KS, Gentry KM, Sambade M, Beck W, Garness J, Entwistle S, Willis C, Vensko S, Woods A, Fini M, Carpenter B, Routh E, Kodysh J, O'Donnell T, et al. Landscape and selection of vaccine epitopes in SARS-CoV-2. Genome Medicine. 13: 101. PMID 34127050 DOI: 10.1186/s13073-021-00910-1 |
0.338 |
|
| 2021 |
Shiuan E, Reddy A, Dudzinski SO, Lim AR, Sugiura A, Hongo R, Young K, Liu XD, Smith CC, O'Neal J, Dahlman KB, McAlister R, Chen B, Ruma K, Roscoe N, et al. Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma. Cancers. 13. PMID 33806963 DOI: 10.3390/cancers13061475 |
0.345 |
|
| 2020 |
Beckermann KE, Hongo R, Ye X, Young K, Carbonell K, Healey DCC, Siska PJ, Barone S, Roe CE, Smith CC, Vincent BG, Mason FM, Irish JM, Rathmell WK, Rathmell JC. CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation. Jci Insight. 5. PMID 32814710 DOI: 10.1172/Jci.Insight.138729 |
0.327 |
|
| 2020 |
Smith CC, Entwistle S, Willis C, Vensko S, Beck W, Garness J, Sambade M, Routh E, Olsen K, Kodysh J, O'Donnell T, Haber C, Heiss K, Stadler V, Garrison E, et al. Landscape and Selection of Vaccine Epitopes in SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 32577654 DOI: 10.1101/2020.06.04.135004 |
0.35 |
|
| 2020 |
Ma X, Shou P, Smith C, Chen Y, Du H, Sun C, Porterfield Kren N, Michaud D, Ahn S, Vincent B, Savoldo B, Pylayeva-Gupta Y, Zhang S, Dotti G, Xu Y. Interleukin-23 engineering improves CAR T cell function in solid tumors. Nature Biotechnology. PMID 32015548 DOI: 10.1038/s41587-019-0398-2 |
0.317 |
|
| 2019 |
Landoni E, Smith CC, Fucá G, Chen Y, Sun C, Vincent BG, Metelitsa LS, Dotti G, Savoldo B. A High Avidity T-Cell Receptor Redirects Natural Killer T-Cell Specificity and Outcompetes the Endogenous Invariant T-Cell Receptor. Cancer Immunology Research. PMID 31719055 DOI: 10.1158/2326-6066.CIR-19-0134 |
0.395 |
|
| 2019 |
Smith CC, Chai S, Washington AR, Lee SJ, Landoni E, Field K, Garness J, Bixby LM, Selitsky SR, Parker JS, Savoldo B, Serody JS, Vincent BG. Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes. Cancer Immunology Research. PMID 31515258 DOI: 10.1158/2326-6066.Cir-19-0155 |
0.562 |
|
| 2019 |
Smith CC, Selitsky SR, Chai S, Armistead PM, Vincent BG, Serody JS. Alternative tumour-specific antigens. Nature Reviews. Cancer. PMID 31278396 DOI: 10.1038/S41568-019-0162-4 |
0.454 |
|
| 2019 |
Selitsky SR, Mose LE, Smith CC, Chai S, Hoadley KA, Dittmer DP, Moschos SJ, Parker JS, Vincent BG. Prognostic value of B cells in cutaneous melanoma. Genome Medicine. 11: 36. PMID 31138334 DOI: 10.1186/S13073-019-0647-5 |
0.357 |
|
| 2018 |
Smith CC, Beckermann KE, Bortone DS, de Cubas AA, Bixby LM, Lee SJ, Panda A, Ganesan S, Bhanot G, Wallen EM, Milowsky MI, Kim WY, Rathmell WK, Swanstrom R, Parker JS, et al. Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma. The Journal of Clinical Investigation. PMID 30137025 DOI: 10.1172/Jci121476 |
0.588 |
|
| 2018 |
Panda A, de Cubas AA, Stein M, Riedlinger G, Kra J, Mayer T, Smith CC, Vincent BG, Serody JS, Beckermann KE, Ganesan S, Bhanot G, Rathmell WK. Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma. Jci Insight. 3. PMID 30135306 DOI: 10.1172/Jci.Insight.121522 |
0.553 |
|
| 2018 |
Hong LK, Chen Y, Smith CC, Montgomery SA, Vincent BG, Dotti G, Savoldo B. CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30+ and CD30- Embryonal Carcinoma via Antigen-dependent and Fas/FasL Interactions. Cancer Immunology Research. PMID 30087115 DOI: 10.1158/2326-6066.CIR-18-0065 |
0.411 |
|
| 2018 |
Saito R, Smith CC, Utsumi T, Bixby LM, Kardos J, Wobker SE, Stewart KG, Chai S, Manocha U, Byrd KM, Damrauer JS, Williams SE, Vincent BG, Kim WY. Molecular subtype-specific immunocompetent models of high-grade urothelial carcinoma reveal differential neoantigen expression and response to immunotherapy. Cancer Research. PMID 29784854 DOI: 10.1158/0008-5472.CAN-18-0173 |
0.488 |
|
| 2018 |
Mi Y, Smith CC, Yang F, Qi Y, Roche KC, Serody JS, Vincent BG, Wang AZ. A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy. Advanced Materials (Deerfield Beach, Fla.). e1706098. PMID 29691900 DOI: 10.1002/Adma.201706098 |
0.503 |
|
| 2018 |
Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, et al. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Reports. 23: 313-326.e5. PMID 29617669 DOI: 10.1016/J.Celrep.2018.03.075 |
0.35 |
|
| 2018 |
Beckford Vera DR, Smith CC, Bixby LM, Glatt DM, Dunn SS, Saito R, Kim WY, Serody JS, Vincent BG, Parrott MC. Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors. Plos One. 13: e0193832. PMID 29513764 DOI: 10.1371/Journal.Pone.0193832 |
0.509 |
|
| Show low-probability matches. |
